While Senate President Don Gaetz tries to play peacemaker over Medicaid funds, asThe Florida Currentreports, a lower-profile debate that requires legislators to study up on biology and economics is playing out in health-policy committees.
That debate, which concerns whether “biosimilar” versions of biologic drugs should be treated as generics, is consuming a lot of time on health-policy committees this session, and the Sarasota Herald-Tribune’s Capitol Bureau Chief Lloyd Dunkelberger explains it.
An issue important to cancer patients -- coverage for chemo in pill form rather than just IVs -- passed the Senate unanimously on Friday but may be stalled in the House Health and Human Services Committee, the Times/Herald Tallahassee Bureaureports.